title: Ductal carcinoma in situ (DCIS) of the breast: diagnostic and therapeutic controversies.
authors.affiliation: Keck School of Medicine, University of Southern California, Los Angeles, USA.
authors.forename: M J
authors.initials: MJ
authors.lastname: Silverstein
authors.forename: R
authors.initials: R
authors.lastname: Parker
authors.forename: J C
authors.initials: JC
authors.lastname: Grotting
authors.forename: R J
authors.initials: RJ
authors.lastname: Cote
authors.forename: C A
authors.initials: CA
authors.lastname: Russell
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects / Q000627:therapeutic use; D001365:Axilla; D001706:Biopsy / Q000295:instrumentation / Q000379:methods; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000628:therapy*; D002285:Carcinoma, Intraductal, Noninfiltrating / Q000175:diagnosis* / Q000628:therapy*; D003131:Combined Modality Therapy; D005260:Female; D020249:Hormone Replacement Therapy / Q000009:adverse effects; D006801:Humans; D008207:Lymphatic Metastasis; D016462:Mammaplasty / Q000379:methods; D008408:Mastectomy / Q000379:methods / Q000534:rehabilitation; D009364:Neoplasm Recurrence, Local; D012307:Risk Factors; D013629:Tamoxifen / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen